Krabbe's Disease

Professional Reference articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.
This page has been archived. It has not been updated since 19/08/2011. External links and references may no longer work.

Synonyms: globoid cell leukodystrophy, globoid cell leukoencephalopathy, galactosylceramide lipidosis, galactosylceramidase (GALC) deficiency

This is an autosomal recessive leukodystrophy. There is a lack of the enzyme galatosylceramidase (GALC) leading to abnormalities of myelin formation in both the central and peripheral nervous system. It is often fatal.

Worldwide it is estimated to affect 1 in 100,000-200,000 births, although a higher incidence occurs in certain groups, eg some Israeli communities.[1, 2] Males and females are equally affected.

The mutation in Krabbe's disease is located to the human chromosome 14 and more than 40 mutations have been identified.[2] This mutation of the galactosylceramidase (GALC) gene leads to a GALC deficiency. Deficiency of this enzyme leads to an inability to break down lipids in the myelin, leading to reduced myelin production. However, it has been observed that this genotype alone may not account for the phenotype, suggesting that other genetic factors may also be important.[2, 3]

There are two types of presentation:

  • Infantile form - the most common, with affected infants being normal at birth. 80% of cases develop features and are diagnosed in the first six months of life.
  • Late-onset form - later presentation including adulthood; rarer and milder, with slower progression.


These usually occur at 3-6 months:[4]

  • Irritability.
  • Crying.
  • Fever.
  • Feeding difficulties.
  • Limb stiffness.
  • Delayed achievement of developmental milestones.
  • Vomiting.
  • Blindness.
  • Seizures.


  • Cherry red spots.
  • Protruding ears.
  • Postural tremor of limbs.
  • Spasticity.
  • Hyperreflexia.
  • Clonus.
  • Pyramidal paresis of limb or limbs.
  • Extensor plantar responses.
  • Unsteadiness of gait.
  • Psychomotor retardation.
  • Dysphagia.
  • Deafness.

Adults commonly present with motor skill problems, paraesthesia, weakness and cognitive deficits.

  • Galactosylceramidase (GALC) enzyme activity - from blood or skin fibroblasts (activity reduced).
  • MRI - demyelination of white matter of the brain and, more rarely, the spinal cord.[5, 6]
  • Lumbar puncture will show raised CSF protein.
  • Nerve conduction - can be normal; however, most have some abnormalities, eg delayed brainstem auditory evoked potentials and visual evoked potentials.
  • Histology - presence of PAS-positive material extracellularly and cerithin in microglial cells with characteristic 'globoid cells' in brain tissue.[2]
  • EEG.
  • Genetic studies.

This can be performed with chorionic villous sampling.[2]

  • There is no cure yet and thus management is mainly supportive, eg physiotherapy, anticonvulsants.
  • Allogeneic haematopoietic stem cell transplantation in early disease leads to reversal of CNS deterioration.[7, 8]
  • Transplantation of umbilical cord blood from unrelated donors leads to neurological improvement in those who received this therapy before the development of symptoms.[9]

Parents and carers will need education and support. Parents will require genetic counselling before further pregnancies.

Poor in infantile forms with death usually before the age of 2 years.[4] However, some cases have been reported to live beyond the teens. In late-onset disease, cases progress slower and the spectrum and severity of the illness are very variable.

Did you find this information useful?

Thanks for your feedback!

Why not subcribe to the newsletter?

We would love to hear your feedback!

  1. Krabbe disease, Genetics Home Reference, US National Library of Medicine
  2. Krabbe Disease, Online Mendelian Inheritance in Man (OMIM)
  3. Xu C, Sakai N, Taniike M, et al; Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J Hum Genet. 2006 51(6):548-54. Epub 2006 Apr 11.
  4. Krabbe disease, PubMed Health, May 2011
  5. Given CA 2nd, Santos CC, Durden DD; Intracranial and spinal MR imaging findings associated with Krabbe's disease: case report. AJNR Am J Neuroradiol. 2001 Oct 22(9):1782-5.
  6. Provenzale JM, Peddi S, Kurtzberg J, et al; Correlation of neurodevelopmental features and MRI findings in infantile Krabbe's AJR Am J Roentgenol. 2009 Jan 192(1):59-65.
  7. Siddiqi ZA, Sanders DB, Massey JM; Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation. Neurology. 2006 Jul 25 67(2):268-72.
  8. McGraw P, Liang L, Escolar M, et al; Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements--initial experience. Radiology. 2005 Jul 236(1):221-30.
  9. Escolar ML, Poe MD, Provenzale JM, et al; Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005 May 19 352(20):2069-81.
Dr Hayley Willacy
Peer Reviewer:
Dr Colin Tidy
Document ID:
2365 (v22)
Last Checked:
19 August 2011
Next Review:
17 August 2016

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. Patient Platform Limited has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.